Search:

Home

HAART

Talking with your patient

GSK's commitment

Resources

Important Safety Information/
Indications > LEXIVA^® (fosamprenavir calcium)
> EPZICOM^® (abacavir sulfate and lamivudine)
> COMBIVIR^® (lamivudine/zidovudine)
> TRIZIVIR^® (abacavir sulfate, lamivudine, and zidovudine)
> ZIAGEN^® (abacavir sulfate)
> EPIVIR^® (lamivudine)
> RETROVIR^® (zidovudine)

Site map

Site map

• TreatHIV HCP homepage
• HAART
• NRTIs
• NNRTIs
• PIs
• FIs
• Talking with your patient
• Newly diagnosed
• In treatment
• Caregivers
• GSK's commitment
• Hope After HIV
• Positive Action
• Resources
• Patient resources
• Healthcare provider resources
• Clinical trial information
• Important Safety Information/Indications
• LEXIVA^® (fosamprenavir calcium)
• EPZICOM^® (abacavir sulfate and lamivudine)
• COMBIVIR^® (lamivudine/zidovudine)
• TRIZIVIR^® (abacavir sulfate, lamivudine, and zidovudine)
• ZIAGEN^® (abacavir sulfate)
• EPIVIR^® (lamivudine)
• RETROVIR^® (zidovudine)